Francesca Castagnoli, Justin Mencel, Derfel Ap Dafydd, Jessica Gough, Brent Drake, Naami Charlotte Mcaddy, Samuel Joseph Withey, Angela Mary Riddell, Dow-Mu Koh, Joshua David Shur
As the management of gastrointestinal malignancy has evolved, tumor response assessment has expanded from size-based assessments to those that include tumor enhancement, in addition to functional data such as those derived from PET and diffusion-weighted imaging. Accurate interpretation of tumor response therefore requires knowledge of imaging modalities used in gastrointestinal malignancy, anticancer therapies, and tumor biology. Targeted therapies such as immunotherapy pose additional considerations due to unique imaging response patterns and drug toxicity; as a consequence, immunotherapy response criteria have been developed...
May 2024: Radiographics: a Review Publication of the Radiological Society of North America, Inc